These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 39066258)

  • 1. A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer.
    Wu M; Guan G; Yin H; Niu Q
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
    Taniguchi Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors.
    Gold S; Shilatifard A
    Curr Opin Genet Dev; 2024 Jun; 86():102181. PubMed ID: 38564841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances of structure and mechanisms of bromodomain-containing protein 4 and its related research in tumors].
    Huang Q; Ding Y; Tan Y; Mo W; Li T; Huang Y; Hao W
    Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):132-148. PubMed ID: 36738206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BET Bromodomain as a Target of Epigenetic Therapy.
    Noguchi-Yachide T
    Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodomain inhibitors and therapeutic applications.
    Gajjela BK; Zhou MM
    Curr Opin Chem Biol; 2023 Aug; 75():102323. PubMed ID: 37207401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoiesis: a BETter understanding.
    Dasgupta N; Adams PD
    EMBO Rep; 2023 Oct; 24(10):e57927. PubMed ID: 37650879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral Hijacking of BET Proteins.
    Chen IP; Ott M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
    Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
    Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system.
    Werner MT; Wang H; Hamagami N; Hsu SC; Yano JA; Stonestrom AJ; Behera V; Zong Y; Mackay JP; Blobel GA
    J Biol Chem; 2020 Feb; 295(7):1898-1914. PubMed ID: 31792058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain and Extraterminal Domain Protein 2 in Multiple Human Diseases.
    Ji Y; Chen W; Wang X
    J Pharmacol Exp Ther; 2024 May; 389(3):277-288. PubMed ID: 38565308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
    Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
    J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRD4 in physiology and pathology: ''BET'' on its partners.
    Liang Y; Tian J; Wu T
    Bioessays; 2021 Dec; 43(12):e2100180. PubMed ID: 34697817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.
    Feng L; Wang G; Chen Y; He G; Liu B; Liu J; Chiang CM; Ouyang L
    Med Res Rev; 2022 Mar; 42(2):710-743. PubMed ID: 34633088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of BET Family Proteins Suppresses African Swine Fever Virus Infection.
    Zhao Y; Niu Q; Yang S; Yang J; Zhang Z; Geng S; Fan J; Liu Z; Guan G; Liu Z; Zhou J; Hu H; Luo J; Yin H
    Microbiol Spectr; 2022 Aug; 10(4):e0241921. PubMed ID: 35758684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
    Faivre EJ; McDaniel KF; Albert DH; Mantena SR; Plotnik JP; Wilcox D; Zhang L; Bui MH; Sheppard GS; Wang L; Sehgal V; Lin X; Huang X; Lu X; Uziel T; Hessler P; Lam LT; Bellin RJ; Mehta G; Fidanze S; Pratt JK; Liu D; Hasvold LA; Sun C; Panchal SC; Nicolette JJ; Fossey SL; Park CH; Longenecker K; Bigelow L; Torrent M; Rosenberg SH; Kati WM; Shen Y
    Nature; 2020 Feb; 578(7794):306-310. PubMed ID: 31969702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis-Brief Report.
    Tzani A; Haemmig S; Cheng HS; Pérez-Cremades D; Heuschkel MA; Jamaiyar A; Singh SA; Aikawa M; Yu PB; Wang T; Sun Y; Feinberg MW; Plutzky J
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):143-155. PubMed ID: 37942611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the epigenetic reader "BET" as a therapeutic strategy for cancer.
    Wahi A; Manchanda N; Jain P; Jadhav HR
    Bioorg Chem; 2023 Nov; 140():106833. PubMed ID: 37683545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.
    Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC
    ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlocking the secrets of aging: Epigenetic reader BRD4 as the target to combatting aging-related diseases.
    Sun J; Gui Y; Zhou S; Zheng XL
    J Adv Res; 2024 Sep; 63():207-218. PubMed ID: 37956861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.